ATE261305T1 - Verwendung einer pyridazinonverbindung als calcium sensibilisator - Google Patents

Verwendung einer pyridazinonverbindung als calcium sensibilisator

Info

Publication number
ATE261305T1
ATE261305T1 AT99928033T AT99928033T ATE261305T1 AT E261305 T1 ATE261305 T1 AT E261305T1 AT 99928033 T AT99928033 T AT 99928033T AT 99928033 T AT99928033 T AT 99928033T AT E261305 T1 ATE261305 T1 AT E261305T1
Authority
AT
Austria
Prior art keywords
pyridazinone compound
calcium sensitizer
treatment
sensitizer
calcium
Prior art date
Application number
AT99928033T
Other languages
English (en)
Inventor
Heimo Haikala
Piero Pollesello
Juha Kaivola
Jouko Levijoki
Original Assignee
Orion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Corp filed Critical Orion Corp
Application granted granted Critical
Publication of ATE261305T1 publication Critical patent/ATE261305T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT99928033T 1998-06-19 1999-05-26 Verwendung einer pyridazinonverbindung als calcium sensibilisator ATE261305T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/099,945 US5905078A (en) 1998-06-19 1998-06-19 Use of a pyridazinone derivative
PCT/FI1999/000449 WO1999066932A1 (en) 1998-06-19 1999-05-26 New use of a pyridazinone derivative

Publications (1)

Publication Number Publication Date
ATE261305T1 true ATE261305T1 (de) 2004-03-15

Family

ID=22277351

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99928033T ATE261305T1 (de) 1998-06-19 1999-05-26 Verwendung einer pyridazinonverbindung als calcium sensibilisator

Country Status (18)

Country Link
US (2) US5905078A (de)
EP (1) EP1087769B1 (de)
JP (1) JP4938928B2 (de)
AT (1) ATE261305T1 (de)
AU (1) AU760379B2 (de)
BR (1) BR9911237A (de)
CA (1) CA2334910C (de)
CZ (1) CZ295283B6 (de)
DE (1) DE69915475T2 (de)
EE (1) EE04658B1 (de)
ES (1) ES2217767T3 (de)
HU (1) HUP0202836A3 (de)
IL (2) IL140032A0 (de)
NZ (1) NZ508444A (de)
PL (1) PL194344B1 (de)
SK (1) SK285004B6 (de)
TR (1) TR200003772T2 (de)
WO (1) WO1999066932A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20011465A0 (fi) * 2001-07-04 2001-07-04 Orion Corp Pyridatsinonijohdannaisen uusi käyttö
FI20040674A0 (fi) 2004-05-12 2004-05-12 Orion Corp Menetelmä tromboembolisten sairauksien estoon
US20080255134A1 (en) * 2004-11-30 2008-10-16 Artesian Therapeutics, Inc. Cardiotonic Compounds With Inhibitory Activity Against Beta-Adrenergic Receptors And Phosphodiesterase
TW200920371A (en) 2007-08-29 2009-05-16 Orion Corp A combination treatment
WO2011027021A1 (en) 2009-09-01 2011-03-10 Orion Corporation A method for the treatment of hypertension
US9915301B2 (en) 2010-10-28 2018-03-13 Ford Global Technologies, Llc Magnetically actuated mechanical diode
US8418825B2 (en) 2010-10-28 2013-04-16 Ford Global Technologies, Llc Magnetically actuated mechanical diode
US9366298B2 (en) 2010-10-28 2016-06-14 Ford Global Technologies, Llc Magnetically actuated clutch assembly
WO2021001601A1 (en) 2019-07-01 2021-01-07 Orion Corporation Methods for administering (r)-n-[4-(1,4,5,6-tetrahydro-6-oxo-3-pyridazinyl)phenyl]acetamide

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3746712A (en) * 1971-06-08 1973-07-17 A Ross 6-(substituted-phenyl)-5-methyl-4,5-dihydro-3(2h)-pyridazinones
US4397854A (en) * 1981-05-14 1983-08-09 Warner-Lambert Company Substituted 6-phenyl-3(2H)-pyridazinones useful as cardiotonic agents
JPS588015A (ja) * 1981-07-06 1983-01-18 Mitsubishi Chem Ind Ltd 強心剤
JP2921933B2 (ja) * 1989-07-14 1999-07-19 帝国臓器製薬株式会社 光学活性酪酸誘導体
GB2251615B (en) * 1991-01-03 1995-02-08 Orion Yhtymae Oy (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazono]pro panedinitrile
JP3131845B2 (ja) * 1991-06-12 2001-02-05 帝国臓器製薬株式会社 慢性心不全治療剤
GB9606474D0 (en) * 1996-03-27 1996-06-05 Orion Yhytmo Oy Method for obtaining pure enantiomers of a pyridazinone derivative
JP3163050B2 (ja) 1997-12-25 2001-05-08 三洋電機株式会社 自動洗髪機

Also Published As

Publication number Publication date
HUP0202836A3 (en) 2003-03-28
DE69915475T2 (de) 2005-03-24
HUP0202836A2 (hu) 2003-02-28
CZ20004554A3 (en) 2001-05-16
WO1999066932A1 (en) 1999-12-29
CZ295283B6 (cs) 2005-06-15
US5905078A (en) 1999-05-18
CA2334910C (en) 2007-10-23
EP1087769A1 (de) 2001-04-04
NZ508444A (en) 2003-03-28
EE04658B1 (et) 2006-08-15
CA2334910A1 (en) 1999-12-29
SK285004B6 (sk) 2006-04-06
EP1087769B1 (de) 2004-03-10
JP4938928B2 (ja) 2012-05-23
SK18732000A3 (sk) 2001-12-03
PL345036A1 (en) 2001-11-19
DE69915475D1 (de) 2004-04-15
IL140032A0 (en) 2002-02-10
ES2217767T3 (es) 2004-11-01
AU4516699A (en) 2000-01-10
IL140032A (en) 2007-05-15
USRE38102E1 (en) 2003-04-29
TR200003772T2 (tr) 2001-06-21
BR9911237A (pt) 2001-03-06
EE200000755A (et) 2002-04-15
AU760379B2 (en) 2003-05-15
PL194344B1 (pl) 2007-05-31
JP2002518450A (ja) 2002-06-25

Similar Documents

Publication Publication Date Title
EA199800667A1 (ru) Новые фенантридины
TR200200205T2 (tr) MEK inhibitörleri kullanılarak kronik ağrının tedavi edilmesi
ES2189235T3 (es) 6-fenilfenantridinas sustituidas.
TR200003333T2 (tr) Ensülin direngenliği ve hiperglisemi tedavisinde yararlı benzotiyofenler
DE59913784D1 (de) Verwendung von Thiazolidinderivaten als antihyperglykämische Mittel
ATE236629T1 (de) Verwendung heterocyclischer verbindungen als dopamin-d 3 liganden
BR9806752A (pt) Ftalazinonas.
ATE93138T1 (de) Verwendung insulin-sensiblisierender wirkstoffe zur behandlung von hypertonie.
NO992282L (no) Benzonaftyridiner som bronkialterapentika
DE69915475D1 (de) Verwendung einer pyridazinonverbindung als calcium sensibilisator
DK0772604T3 (da) Trialzolforbindelser og deres anvendelse som dopamin-D3-ligander
TR199700206A2 (xx) Floralkil- ve floralkoksi ikame edilmi� heterosiklik bradikinin-antagonistleri, bunlar�n imal edilmesine mahsus usul ve bunlar�n kullan�lmalar�.
DE69025206T2 (de) Verwendung von aromatischen benzoaten als deodorants
EA199800019A1 (ru) Способ повышения плотности кальциевых каналов
DK0986393T3 (da) Anvendelse af et nitroxid eller et prodrug heraf ved profylaktisk og terapeutisk behandling af cancer
DE58903912D1 (de) Verwendung von 2-substituierten ethansulfonverbindungen als galvanotechnische hilfsstoffe.
EA200001098A1 (ru) Пероральные композиции с контролируемым высвобождением левозимендана
FR2707990B1 (fr) Nouvelles nitrones utilisables pour le piégeage des radicaux libres.
EE04355B1 (et) Levosimendani kasutamine kopsuhüpertensiooni ravimi tootmises
DE69623767D1 (de) Verwendung von pyrrolidinderivaten zur behandlung des alkoholismus
PE20001145A1 (es) Mezclas fungicidas
NO159018C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive disubstituerte polymetyleniminer.
DE60217336D1 (de) Verwendung eines pyridazinon derivates zur behandlung des kongestiven herzversagens
EA200200100A1 (ru) Способ лечения или профилактики вазоспазма коронарного трансплантата
EA199800033A1 (ru) Антагонисты канала кальция

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties